11 December 2019 : Laboratory Research
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma
Tao Liu1ABCDEF, Chenyao Li1AB, Lipeng Jin1BD, Chao Li1ACDEF*, Lei Wang1ABCDEFGDOI: 10.12659/MSM.920381
Med Sci Monit 2019; 25:9435-9445
Abstract
BACKGROUND: The RNA-seq FPKM data of 331 colorectal adenocarcinoma samples in The Cancer Genome Atlas database with matching clinical data were analyzed in order to reveal the prognostic value of m6A RNA methylation regulators in colon adenocarcinoma.
MATERIAL AND METHODS: The expression of 13 m6A RNA methylated regulators in samples were analyzed. The samples were classified into Cluster I and II by consistent clustering. The gene distribution was analyzed by principal component analysis. Further functional analysis of selected m6A RNA genes was performed and potential risk characteristics was developed using Lasso Cox regression algorithm. Using minimum criteria, the risk coefficients of YTHDF1 and HNRNPC were detected for Cluster II. Patients were divided into high-risk and low-risk subgroups based on the risk characteristics. The clinical data were analyzed by univariate and multivariate Cox regression analysis.
RESULTS: Expression of the detected m6A RNA methylated regulators except YTHDC2 in tumors were significantly different from their adjacent mucosa. Among them, only ALKBH5 and METTL4 were downregulated in tumors. The gene distribution between the 2 subgroups were different. The expression of m6A RNA methylation regulators including YTHDF1, HNRNPC, YTHDC2, YTHDC1, ZC3H13, and RBM15 were different between the 2 groups (P<0.05). The prognostic characteristics between the high-risk and low-risk groups were significant different (P<0.05), which had a good predictive significance of prognosis area under the curve (AUC)=0.62). Risk scores were less than 0.05, suggesting risk score was an independent prognostic factor for colon adenocarcinoma.
CONCLUSIONS: m6A RNA methylation regulators YTHDF1 and HNRNPC can be used as prognostic factors of colon cancer, which has potential value for colon cancer treatment.
Keywords: Colorectal Neoplasms, Hereditary Nonpolyposis, Methyltransferases, RNA Processing, Post-Transcriptional, Adenosine Triphosphatases, Algorithms, Cluster Analysis, Colon, Colonic Neoplasms, Databases, Genetic, Heterogeneous-Nuclear Ribonucleoprotein Group C, Methylation, Multivariate Analysis, RNA, RNA Helicases, RNA-Binding Proteins, tRNA Methyltransferases
Editorial
01 September 2024 : Editorial
Editorial: Reasons for Increasing Global Concerns for the Spread of MpoxDOI: 10.12659/MSM.946343
Med Sci Monit 2024; 30:e946343
In Press
Review article
Pharmacological Strategies in Dermatomyositis: Current Treatments and Future DirectionsMed Sci Monit In Press; DOI: 10.12659/MSM.944564
Clinical Research
Effect of Hyaluronic Acid on Socket Healing After Lower Impacted Third Molar Tooth Extraction in 40 Dental ...Med Sci Monit In Press; DOI: 10.12659/MSM.945386
Review article
Cariprazine in Psychiatry: A Comprehensive Review of Efficacy, Safety, and Therapeutic PotentialMed Sci Monit In Press; DOI: 10.12659/MSM.945411
Clinical Research
Influenza Hemagglutinin Antibody Levels in the Elderly: Impact of Sex, Age, and Influenza/COVID-19 Vaccinat...Med Sci Monit In Press; DOI: 10.12659/MSM.945002
Most Viewed Current Articles
17 Jan 2024 : Review article 6,049,426
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,832,003
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 692,876
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 257,339
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074